Phathom Pharmaceuticals
World Rank (Jan-05-2024)
12,344
Market Cap (Jan-05-2024)
0.521 Billion USD
World Rank (Jul-30-2023)
9,683
Market Cap (Jul-30-2023)
0.835 Billion USD
World Rank (Dec-25-2022)
12,820
Market Cap (Dec-25-2022)
0.470 Billion USD
World Rank (Jan-07-2022)
13,041
Market Cap (Jan-07-2022)
0.53 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-197 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Phathom Pharmaceuticals is a Clinical Stage Biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid related gastrointestinal (GI) disorders. The company annual revenue is approximately 74.5 million USD, total assets is 263.9 million USD and 16 employees as on 2019. The headquarters is in USA.
Company Website